Shares

49 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$63.15 - $72.88 $1.1 Billion - $1.27 Billion
17,389,057 New
17,389,057 $1.19 Billion
Q4 2023

Feb 09, 2024

BUY
$73.27 - $83.09 $1.18 Billion - $1.34 Billion
16,067,445 New
16,067,445 $1.3 Billion
Q3 2023

Nov 13, 2024

BUY
$73.94 - $80.67 $1.09 Billion - $1.18 Billion
14,674,535 New
14,674,535 $1.1 Billion
Q3 2023

Nov 13, 2023

SELL
$73.94 - $80.67 $971 Million - $1.06 Billion
-13,125,530 Closed
0 $0
Q2 2023

Aug 14, 2024

SELL
$76.01 - $86.7 $220 Million - $251 Million
-2,890,960 Reduced 16.63%
14,498,097 $1.12 Billion
Q2 2023

Aug 14, 2023

SELL
$76.01 - $86.7 $935 Million - $1.07 Billion
-12,298,066 Closed
0 $0
Q1 2023

May 15, 2024

BUY
$77.31 - $88.08 $1.09 Billion - $1.24 Billion
14,129,857 New
14,129,857 $1.17 Billion
Q4 2022

Feb 14, 2023

BUY
$62.32 - $89.47 $810 Million - $1.16 Billion
12,989,939 New
12,989,939 $1.12 Billion
Q3 2022

Nov 13, 2023

BUY
$59.54 - $68.01 $781 Million - $893 Million
13,125,530 New
13,125,530 $810 Million
Q2 2022

Aug 14, 2023

BUY
$57.72 - $65.01 $710 Million - $799 Million
12,298,066 New
12,298,066 $760 Million
Q1 2022

May 12, 2023

SELL
$57.92 - $72.58 $35.5 Million - $44.4 Million
-612,259 Reduced 4.71%
12,377,680 $736 Million
Q1 2022

May 09, 2022

SELL
$57.92 - $72.58 $759 Million - $951 Million
-13,096,141 Closed
0 $0
Q4 2021

Mar 09, 2022

BUY
$64.88 - $73.64 $850 Million - $964 Million
13,096,141 New
13,096,141 $951 Million
Q3 2021

Nov 14, 2022

BUY
$67.69 - $73.03 $890 Million - $960 Million
13,150,666 New
13,150,666 $919 Million
Q3 2021

Nov 05, 2021

SELL
$67.69 - $73.03 $900 Million - $971 Million
-13,301,447 Closed
0 $0
Q2 2021

Aug 15, 2022

BUY
$63.47 - $69.35 $844 Million - $922 Million
13,301,447 New
13,301,447 $916 Million
Q2 2021

Aug 10, 2021

SELL
$63.47 - $69.35 $877 Million - $958 Million
-13,820,473 Closed
0 $0
Q1 2021

May 09, 2022

BUY
$60.0 - $68.46 $829 Million - $946 Million
13,820,473 New
13,820,473 $893 Million
Q1 2021

May 07, 2021

SELL
$60.0 - $68.46 $790 Million - $902 Million
-13,174,527 Closed
0 $0
Q4 2020

Mar 02, 2021

BUY
$56.65 - $64.55 $746 Million - $850 Million
13,174,527 New
13,174,527 $768 Million
Q4 2020

Feb 10, 2021

SELL
$56.65 - $64.55 $750 Million - $855 Million
-13,241,995 Closed
0 $0
Q3 2020

Nov 12, 2021

BUY
$62.1 - $78.08 $822 Million - $1.03 Billion
13,241,995 New
13,241,995 $837 Million
Q3 2020

Nov 10, 2020

SELL
$62.1 - $78.08 $803 Million - $1.01 Billion
-12,927,129 Closed
0 $0
Q2 2020

Aug 13, 2021

BUY
$72.34 - $84.0 $935 Million - $1.09 Billion
12,927,129 New
12,927,129 $995 Million
Q2 2020

Aug 07, 2020

SELL
$72.34 - $84.0 $1.03 Billion - $1.19 Billion
-14,186,641 Closed
0 $0
Q1 2020

May 07, 2021

BUY
$62.63 - $80.22 $889 Million - $1.14 Billion
14,186,641 New
14,186,641 $1.06 Billion
Q1 2020

May 08, 2020

SELL
$62.63 - $80.22 $829 Million - $1.06 Billion
-13,228,713 Closed
0 $0
Q4 2019

Mar 03, 2020

BUY
$61.62 - $67.78 $815 Million - $897 Million
13,228,713 New
13,228,713 $860 Million
Q4 2019

Feb 12, 2020

SELL
$61.62 - $67.78 $831 Million - $914 Million
-13,486,713 Closed
0 $0
Q3 2019

Nov 13, 2020

BUY
$62.51 - $69.0 $843 Million - $931 Million
13,486,713 New
13,486,713 $855 Million
Q3 2019

Nov 08, 2019

SELL
$62.51 - $69.0 $838 Million - $925 Million
-13,412,617 Closed
0 $0
Q2 2019

Aug 13, 2020

BUY
$61.87 - $69.38 $830 Million - $931 Million
13,412,617 New
13,412,617 $906 Million
Q2 2019

Aug 09, 2019

SELL
$61.87 - $69.38 $819 Million - $918 Million
-13,231,243 Closed
0 $0
Q1 2019

May 11, 2020

BUY
$62.53 - $70.05 $28.7 Million - $32.2 Million
459,358 Added 3.6%
13,231,243 $860 Million
Q4 2018

Mar 04, 2019

BUY
$60.54 - $79.0 $773 Million - $1.01 Billion
12,771,885 New
12,771,885 $799 Million
Q4 2018

Feb 08, 2019

SELL
$60.54 - $79.0 $765 Million - $999 Million
-12,642,921 Closed
0 $0
Q3 2018

Nov 12, 2019

BUY
$71.28 - $78.92 $901 Million - $998 Million
12,642,921 New
12,642,921 $976 Million
Q3 2018

Nov 09, 2018

SELL
$71.28 - $78.92 $901 Million - $998 Million
-12,642,921 Closed
0 $0
Q2 2018

Aug 12, 2019

BUY
$64.88 - $75.68 $820 Million - $957 Million
12,642,921 New
12,642,921 $896 Million
Q2 2018

Jul 23, 2018

SELL
$64.88 - $75.68 $833 Million - $971 Million
-12,833,872 Closed
0 $0
Q1 2018

May 15, 2019

BUY
$72.84 - $88.8 $935 Million - $1.14 Billion
12,833,872 New
12,833,872 $968 Million
Q1 2018

May 09, 2018

SELL
$72.84 - $88.8 $913 Million - $1.11 Billion
-12,539,377 Closed
0 $0
Q4 2017

Mar 05, 2018

BUY
$71.15 - $83.52 $892 Million - $1.05 Billion
12,539,377 New
12,539,377 $898 Million
Q4 2017

Feb 09, 2018

SELL
$71.15 - $83.52 $892 Million - $1.05 Billion
-12,539,377 Closed
0 $0
Q3 2017

Nov 13, 2018

BUY
$72.11 - $85.47 $904 Million - $1.07 Billion
12,539,377 New
12,539,377 $1.02 Billion
Q3 2017

Nov 07, 2017

SELL
$72.11 - $85.47 $892 Million - $1.06 Billion
-12,376,298 Closed
0 $0
Q2 2017

Jul 24, 2018

SELL
N/A
-922,350 Reduced 6.94%
12,376,298 $876 Million
Q1 2017

May 11, 2018

SELL
N/A
-486,779 Reduced 3.53%
13,298,648 $903 Million
Q3 2016

Nov 13, 2017

BUY
N/A
13,785,427
13,785,427 $0

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.